Cryptococcus neoformans can utilize ferritin as an iron source.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
18 Aug 2022
Historique:
received: 03 05 2022
revised: 11 07 2022
accepted: 06 08 2022
pubmed: 10 8 2022
medline: 21 1 2023
entrez: 9 8 2022
Statut: ppublish

Résumé

Ferritin, a major iron storage protein in vertebrates, supplies iron upon iron deficiency. Ferritin is also found extracellularly, and acts as an iron carrier and a contributor to the immune response to invading microbes. Some microbial pathogens take advantage of ferritin as an iron source upon infection. However, no information is currently available on whether the human fungal pathogen Cryptococcus neoformans can acquire iron from ferritin. Here, we found that C. neoformans grew well in the presence of ferritin as a sole iron source. We showed that the binding of ferritin to the surface of C. neoformans is necessary and that acidification may contribute to ferritin-iron utilization by the fungus. Our data also revealed that the high-affinity reductive iron uptake system in C. neoformans is required for ferritin-iron acquisition. Furthermore, phagocytosis of C. neoformans by macrophages led to increased intracellular ferritin levels, suggesting that iron is sequestered by ferritin in infected macrophages. The increase in intracellular ferritin levels was reversed upon infection with a C. neoformans mutant deficient in the high-affinity reductive iron uptake system, indicating that this system plays a major role in iron acquisition in the phagocytosed C. neoformans in macrophages. Cryptococcus neoformans is an opportunistic fungal pathogen causing life-threatening pulmonary disease and cryptococcal meningitis, mainly in immunocompromised patients. In this study, we found that C. neoformans can use ferritin, a major iron storage protein in vertebrates, as a sole iron source.

Identifiants

pubmed: 35943215
pii: 6658873
doi: 10.1093/mmy/myac056
pmc: PMC9387142
pii:
doi:

Substances chimiques

Iron E1UOL152H7
Ferritins 9007-73-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI053721
Pays : United States
Organisme : National Research Foundation of Korea
Organisme : Ministry of Science, ICT and Future Planning
Organisme : National Institute of Allergy and Infectious Diseases
Organisme : Burroughs Wellcome Fund
Organisme : Canadian Institute for Advanced Research

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Moonyong Song (M)

Department of Systems Biotechnology, Chung-Ang University, Anseong 17546, Korea.

Eun Jung Thak (EJ)

Department of Life Science, Chung-Ang University, Seoul 06974, Korea.

Hyun Ah Kang (HA)

Department of Life Science, Chung-Ang University, Seoul 06974, Korea.

James W Kronstad (JW)

Michael Smith Laboratories, Department of Microbiology & Immunology, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Won Hee Jung (WH)

Department of Systems Biotechnology, Chung-Ang University, Anseong 17546, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH